检测转移性乳腺癌的无创产前检测：病例报告和文献综述

IF 0.2 Q4 ONCOLOGY Current problems in cancer. Case reports Pub Date : 2024-01-01 DOI:10.1016/j.cpccr.2023.100277

Gabriel Francisco Pereira Aleixo , Holly Pederson , Nancy Dalpiaz , Jame Abraham

{"title":"检测转移性乳腺癌的无创产前检测：病例报告和文献综述","authors":"Gabriel Francisco Pereira Aleixo , Holly Pederson , Nancy Dalpiaz , Jame Abraham","doi":"10.1016/j.cpccr.2023.100277","DOIUrl":null,"url":null,"abstract":"<div><p>Noninvasive prenatal testing (NIPT) analyzes placental cell-free DNA in maternal blood for genetic abnormalities, especially in pregnant women of advanced maternal age. It is a high-sensitivity and specificity test used for screening fetal chromosome trisomy 13, 18, 21, sex chromosome aneuploidy, and rare fetal chromosome aneuploidy. Rarely there were cases in which it was used to diagnose maternal cancer. We will discuss a case of metastatic breast cancer diagnosed by NIPT and current knowledge on the use of this technology in diagnosing cancer during pregnancy.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100277"},"PeriodicalIF":0.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000613/pdfft?md5=7b55634122888285d9962acb319ddb46&pid=1-s2.0-S2666621923000613-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Noninvasive prenatal testing detecting metastatic breast cancer: Case report and literature review\",\"authors\":\"Gabriel Francisco Pereira Aleixo , Holly Pederson , Nancy Dalpiaz , Jame Abraham\",\"doi\":\"10.1016/j.cpccr.2023.100277\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Noninvasive prenatal testing (NIPT) analyzes placental cell-free DNA in maternal blood for genetic abnormalities, especially in pregnant women of advanced maternal age. It is a high-sensitivity and specificity test used for screening fetal chromosome trisomy 13, 18, 21, sex chromosome aneuploidy, and rare fetal chromosome aneuploidy. Rarely there were cases in which it was used to diagnose maternal cancer. We will discuss a case of metastatic breast cancer diagnosed by NIPT and current knowledge on the use of this technology in diagnosing cancer during pregnancy.</p></div>\",\"PeriodicalId\":72741,\"journal\":{\"name\":\"Current problems in cancer. Case reports\",\"volume\":\"13 \",\"pages\":\"Article 100277\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666621923000613/pdfft?md5=7b55634122888285d9962acb319ddb46&pid=1-s2.0-S2666621923000613-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current problems in cancer. Case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666621923000613\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current problems in cancer. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666621923000613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

无创产前检测（NIPT）分析母体血液中胎盘无细胞 DNA 的遗传异常，尤其适用于高龄产妇。它是一种高灵敏度和特异性的检测方法，用于筛查胎儿染色体 13、18、21 三体综合征、性染色体非整倍体和罕见的胎儿染色体非整倍体。很少有病例用它来诊断母体癌症。我们将讨论一例通过 NIPT 诊断出的转移性乳腺癌病例，以及目前使用该技术诊断孕期癌症的相关知识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Noninvasive prenatal testing detecting metastatic breast cancer: Case report and literature review

Noninvasive prenatal testing (NIPT) analyzes placental cell-free DNA in maternal blood for genetic abnormalities, especially in pregnant women of advanced maternal age. It is a high-sensitivity and specificity test used for screening fetal chromosome trisomy 13, 18, 21, sex chromosome aneuploidy, and rare fetal chromosome aneuploidy. Rarely there were cases in which it was used to diagnose maternal cancer. We will discuss a case of metastatic breast cancer diagnosed by NIPT and current knowledge on the use of this technology in diagnosing cancer during pregnancy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊